neuroLytixs Patents

Patent portfolio assigned to neuroLytixs (verified via public assignee records). Toronto/London-Ontario blood-based concussion (mTBI) diagnostics using AI + metabolomics. US patent secured Aug 2022 (has_patents=true; exact count not visible). Competitors are TBI/concussion blood-diagnostic peers.